Hostname: page-component-586b7cd67f-t7fkt Total loading time: 0 Render date: 2024-11-24T04:37:50.075Z Has data issue: false hasContentIssue false
  • English
  • Français

A Rating Scale for Evaluation of the Clinical Course and Symptomatology in Amphetamine Psychosis

Published online by Cambridge University Press:  29 January 2018

L. E. Jönsson  and
K. Sjöström
L. E. Jönsson
Affiliation:
Psychiatric Research Center, University of Uppsala, Ulleråker Hospital, 750 17 Uppsala, Sweden
K. Sjöström
Affiliation:
Psychiatric Research Center, University of Uppsala, Ulleråker Hospital, 750 17 Uppsala, Sweden
Get access Rights & Permissions [Opens in a new window]

Extract

Oral intake of amphetamine may cause the development of a schizophrenia-like paranoid psychosis (Monroe and Drell 1947, Connell 1958, Kiloh and Brandon 1962). Intravenous abuse of the drug causes more intense psychotic manifestations dominated by vivid visual and auditory hallucinations (Connell 1958, Kramer et al. 1967, Rylander 1967, Cohen 1968). In the present investigation a rating scale, was designed for the study of amphetamine psychosis in 15 intravenous abusers. A preliminary report of this work has been given earlier (Jönsson and Gunne 1969).

Type
Research Article
Information
The British Journal of Psychiatry , Volume 117 , Issue 541 , December 1970 , pp. 661 - 665
Copyright
Copyright © The Royal College of Psychiatrists, 1970 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Änggård, E., Gunne, L.-M., and Niklasson, F. ‘Gas chromatographic determination of amphetamine in blood, tissue and urine.’ Scand. J. clin. Lab. Invest. In press.Google Scholar
Beckett, A. H., and Rowland, M. (1965). ‘Urinary excretion kinetics of amphetamine in man.’ Pharm. Pharmacol., 17, 628–39.Google Scholar
Cohen, S. (1968). ‘Abuse of centrally stimulating agents among juveniles in California.’ In Abuse of Central Stimulants. Almqvist and Wiksell, Stockholm.Google Scholar
Connell, P. H. (1958). Amphetamine Psychosis. Chapman and Hall Ltd., London.Google Scholar
Dole, V. P., Kim, W. K., and Eglitis, J. (1966). ‘Detection of narcotic drugs, tranquilizers, amphetamines and barbiturates in urine.’ J.A.M.A., 198, 349–52.Google Scholar
Jönsson, L.-E., and Gunne, L.-M. (1969). ‘Clinical studies of amphetamine psychosis.’ International Amphetamine Symp., Milan.Google Scholar
Kiloh, L. G., and Brandon, S. (1962). ‘Habituation and addiction to amphetamines.’ Brit. med. J., ii, 40–3.Google Scholar
Kramer, J. C., Fischman, U. S., and Littlefield, D. S. (1967). ‘Amphetamine abuse.’ J.A.M.A., 201, 305–309.CrossRefGoogle ScholarPubMed
Lorr, M., Klett, G. J., and McNair, D. M. (1963). Syndromes of Psychosis. Pergamon Press, New York.Google Scholar
Monroe, R. R., and Drell, H. J. (1947). ‘Oral use of stimulants obtained from inhalers.’ J.A.M.A., 135, 909–15.Google Scholar
Overall, J. E., and Gorham, D. R. (1962). ‘The brief psychiatric rating scale.’ Psychol. Rep., 10, 799–812.Google Scholar
Rylander, G. (1967). ‘Addiction to Preludin intravenously injected.’ Excerpta med. Int. Congr., Series 150.Google Scholar
Siegel, S. (1956). Nonparametric Statistics. McGraw-Hill Book Company, Inc., 75–83 and 202-13.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.